89bio Statistics
Share Statistics
89bio has 145.98M
shares outstanding. The number of shares has increased by 37.84%
in one year.
| 145.98M |
| 37.84% |
| 0% |
| 99.99% |
| 141.41M |
| 4,789 |
| 0.25% |
Short Selling Information
The latest short interest is 15.46M, so 10.59% of the outstanding
shares have been sold short.
| 15.46M |
| 10.59% |
| 14.74% |
| 10.54 |
Valuation Ratios
The PE ratio is -2.23 and the forward
PE ratio is -4.11.
89bio's PEG ratio is
-0.03.
| -2.23 |
| -4.11 |
| 0 |
| 358.1 |
| 2.04 |
| -2.23 |
| -0.03 |
Financial Ratio History Enterprise Valuation
Currently the Enterprise Value (EV) is not available for 89bio.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 13.19,
with a Debt / Equity ratio of 0.09.
| 13.19 |
| 13.19 |
| 0.09 |
| -0.1 |
| -0.1 |
| 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| n/a |
| $-3.95M |
| 93 |
| 0 |
| n/a |
Taxes
| 692K |
| -0.19% |
Stock Price Statistics
The stock price has increased by 12.02% in the
last 52 weeks. The beta is 1.36, so 89bio's
price volatility has been higher than the market average.
| 1.36 |
| 12.02% |
| 9.99 |
| 8.68 |
| 40.98 |
| 1,908,288 |
Income Statement
| n/a |
| n/a |
| -384.66M |
| -367.08M |
| -384.66M |
| -371.68M |
| -3.51 |
Full Income Statement Balance Sheet
The company has 126.06M in cash and 37.55M in
debt, giving a net cash position of 88.51M.
| 126.06M |
| 37.55M |
| 88.51M |
| -824.51M |
| 685.03M |
| 645.06M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -367.82M
and capital expenditures -15K, giving a free cash flow of -367.84M.
| -367.82M |
| -15K |
| -367.84M |
| -3.51 |
Full Cash Flow Statement Margins
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |